Yield Theory

Lisa McClain · ROIV

Lisa McClain's ROIV trades

Every Roivant Sciences Ltd. - Common Shares transaction Lisa McClain reported to the House Clerk in 2025 and 2026, from the original periodic transaction reports.
Transactions
4
Buys / sells
2 / 2
Disclosed range
$4K – $60K
Last filed
2025-11-21

ROIV transactions reported by Lisa McClain

4 of 4 rows
TypeOwner
Roivant Sciences Ltd. - Common Shares
ROIV
SaleSpouse$1,001 - $15,0002025-11-21
#20033446
Roivant Sciences Ltd. - Common Shares
ROIV
SaleSpouse$1,001 - $15,0002025-11-21
#20033446
Roivant Sciences Ltd. - Common Shares
ROIV
PurchaseSpouse$1,001 - $15,0002025-11-21
#20033446
Roivant Sciences Ltd. - Common Shares
ROIV
PurchaseSpouse$1,001 - $15,0002025-08-13
#20030891

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

The tracker is free

A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.

Get this month’s call for $15

Lisa McClain and ROIV — questions

Did Lisa McClain buy or sell ROIV?

House Clerk filings for 2025 and 2026 show 2 purchases and 2 sales of Roivant Sciences Ltd. - Common Shares (ROIV) reported by Lisa McClain, between 2025-06-17 and 2025-10-31. Reported owner: Spouse.

How much ROIV did Lisa McClain trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $4K – $60K across 4 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last ROIV filing by Lisa McClain?

The most recent periodic transaction report containing a ROIV row was filed on 2025-11-21. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with Roivant Sciences Ltd. - Common Shares. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

Lisa McClain ROIV disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included